ritonavir

Drugs linked to heart risks, minimal

Graham Stocks — Wed, 25 May 2011 23:36:20 -0700

A Canadian study has associated abacavir, efavirenz, lopinavir and ritonavir with an increased risk of heart attackA life-threatening emergency in which the blood supply to the heart is suddenly cut off, causing the heart muscle (myocardium) to die from lack of oxygen.. The research also showed that patients with HIV had twice the risk of heart attack compared to matched HIV
negative controls.

Saquinavir warning

Graham Stocks — Wed, 01 Dec 2010 16:17:22 -0800

The US Food and Drug AdministrationThe U.S. Department of Health and Human Services agency responsible for ensuring the safety and effectiveness of all drugs, biologics, vaccines, and medical devices, including those used in the diagnosis, treatment, and prevention of HIV infection, AIDS, and AIDS-related opportunistic infections. The FDA also works with the blood banking industry to safeguard the nation's blood supply. The Australian equivalent is the Therapeutic Goods Administration (TGA). and the European Medicines Agency have strengthened their warnings to doctors and patients about the potential of the HIV protease inhibitorA type of anti-HIV drug that works by preventing the production of an enzyme, protease, that HIV needs to replicate. saquinavir (Invirase) to cause disturbances in electrical activity in the heart leading to abnormal heart rhythm when the drug is combined with a boosting dose of ritonavir (Norvir).

HAART on the heart

Jill Sergeant — Thu, 04 Jun 2009 23:20:40 -0700

Starting Highly Active AntiretroviralA medication or other substance which is active against retroviruses such as HIV. Therapy can improve some of the things that lead to heart problems but not all of them, a recent study has revealed. Arteries which are already thickened or hardened do not improve on treatment. Metabolic complications, including increases in blood levels of lipids, are common in people on treatment and can also contribute to this condition.

Treatment news from CROI

Paul Kidd — Thu, 12 Mar 2009 17:35:40 -0700

John Daye reports on treatments developments from the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in Montréal, Canada.

Much more than a junket

Paul Kidd — Wed, 12 Oct 2005 07:08:03 -0700

A report from the 3rd IAS Conference on HIV Pathogenesis and Treatment, held in Rio de Janiero in July.

News and treatments briefs

Paul Kidd — Sat, 14 Feb 2004 12:00:10 -0800

HIV-related news in brief from the Feb-Mar 2004 edition of Positive Living.

The power of one

Paul Kidd — Sun, 14 Dec 2003 12:00:21 -0800

We all want simpler treatment regimens with fewer side effects and no meal restrictions, right? Well how does once-a-day treatment sound? As PAUL KIDD reports, it may be closer than you think.